Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kammer

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Annals of Internal Medicine|February 1, 1981
Immune complex assays in rheumatoid disordersG M Kammer
The Journal of Clinical Investigation|April 21, 2005
Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigmGary M Kammer
Arthritis and Rheumatism|July 14, 1999
High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosusG M Kammer
The Journal of Clinical Investigation|November 1, 1983
Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyteG M Kammer
Nature Medicine|November 29, 2002
Immunotherapy tackles lupusGary M Kammer
Annals of the New York Academy of Sciences|July 18, 2002
Deficient protein kinase a in systemic lupus erythematosus: a disorder of T lymphocyte signal transductionGary M Kammer
The Journal of Laboratory and Clinical Medicine|September 1, 1987
Adenosine: emerging role as an immunomodifying agentG M Kammer
The Pennsylvania Nurse|November 1, 1987
Critical health problems of critical concernB M Kammer
Lancet (London, England)|January 4, 1986
AdenosineG M Kammer
Immunology Today|July 1, 1988
The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune responseG M Kammer
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Annals of Internal Medicine|February 1, 1981
Immune complex assays in rheumatoid disordersG M Kammer
The Journal of Clinical Investigation|April 21, 2005
Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigmGary M Kammer
Arthritis and Rheumatism|July 14, 1999
High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosusG M Kammer
The Journal of Clinical Investigation|November 1, 1983
Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyteG M Kammer
Nature Medicine|November 29, 2002
Immunotherapy tackles lupusGary M Kammer
Annals of the New York Academy of Sciences|July 18, 2002
Deficient protein kinase a in systemic lupus erythematosus: a disorder of T lymphocyte signal transductionGary M Kammer
The Journal of Laboratory and Clinical Medicine|September 1, 1987
Adenosine: emerging role as an immunomodifying agentG M Kammer
The Pennsylvania Nurse|November 1, 1987
Critical health problems of critical concernB M Kammer
Lancet (London, England)|January 4, 1986
AdenosineG M Kammer
Immunology Today|July 1, 1988
The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune responseG M Kammer
Pageof 10